Posted 12/9/2023, 3:00:00 PM
Biden Proposes $11 Billion Plan to Eradicate Hepatitis C, But Faces Hurdles in Ensuring Access and Affordability
- Biden's $11B plan aims to eradicate hepatitis C but may overpay drug companies compared to what's needed
- State subscription models have not treated enough patients due to issues finding and supporting them
- Administrative actions could enable private sector solutions without congressional approval
- Allowing drug companies to bundle outreach services with treatments could expand access and cut costs
- Waiting for Congress could drive up costs and deaths; action is needed now before patents expire